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he small GTPases of the Rho family are intimately in-
volved in integrin-mediated changes in the actin cy-
toskeleton that accompany cell spreading and motility.
The exact means by which the Rho family members elicit
these changes is unclear. Here, we demonstrate that the in-
teraction of paxillin via its LD4 motif with the putative
ARF-GAP paxillin kinase linker (PKL) (Turner et al., 1999),
 
is critically involved in the regulation of Rac-dependent
changes in the actin cytoskeleton that accompany cell
spreading and motility. Overexpression of a paxillin LD4 de-
 
letion mutant (paxillin
 
 
 
LD4) in CHO.K1 ﬁbroblasts caused
the generation of multiple broad lamellipodia. These mor-
phological changes were accompanied by an increase in
cell protrusiveness and random motility, which correlated
T
 
with prolonged activation of Rac. In contrast, directional
motility was inhibited. These alterations in morphology and
motility were dependent on a paxillin–PKL interaction. In
 
cells overexpressing paxillin
 
 
 
LD4 mutants, PKL localization
to focal contacts was disrupted, whereas that of focal adhe-
sion kinase (FAK) and vinculin was not. In addition, FAK ac-
tivity during spreading was not compromised by deletion of
the paxillin LD4 motif. Furthermore, overexpression of PKL
mutants lacking the paxillin-binding site (PKL
 
 
 
PBS2) in-
duced phenotypic changes reminiscent of paxillin
 
 
 
LD4
mutant cells. These data suggest that the paxillin association
with PKL is essential for normal integrin-mediated cell
spreading, and locomotion and that this interaction is nec-
essary for the regulation of Rac activity during these events.
 
Introduction
 
Signals that derive from cell adhesion to the extracellular
matrix (ECM)* regulate important physiological events in-
cluding cell motility and growth, and most often involve
changes in the organization of the actin cytoskeleton. Cells
interact with the ECM via transmembrane receptors, termed
integrins, located at the cell surface. Binding of integrins to
the ECM is accompanied by a localized clustering of these
receptors, with the subsequent recruitment of structural and
signaling molecules to the sites of matrix attachment, focal
contacts, providing links to the actin cytoskeleton (Schwartz
et al., 1995; Burridge and Chrzanowska-Wodnicka, 1996).
Regulation of the actin cytoskeletal dynamics that occur
after the activation of integrins via engagement with the
ECM is effected primarily by the Rho family of small
GTPases, i.e., Cdc42, Rac, and Rho (Hall, 1994, 1998;
Hotchin and Hall, 1995; Clark et al., 1998; Price et al.,
1998). Activation of Cdc42 and Rac elicit the formation of
filopodia, and lamellipodia and peripheral membrane ruffles
respectively, as well as focal contacts (Ridley et al., 1992;
Nobes and Hall, 1995). Rho activation propagates the for-
mation of actin stress fibers and focal contacts (Ridley and
Hall, 1992). Multiple effector molecules have been impli-
cated in Rho family signaling including the p21-activated
kinase (PAK), the partner of Rac 1 (POR1), the Wiskott-
Aldrich syndrome protein, the Rho kinase family, and PI-4-P5
kinase (Bishop and Hall, 2000).
PAK binds to and is activated by both Cdc42 and Rac
(Manser et al., 1994; Martin et al., 1995; Knaus and
Bokoch, 1998) and has been implicated in both Cdc42 and
Rac-dependent changes in the actin cytoskeleton (Sells et al.,
1997, 1999; Obermeier et al., 1998; Zhao et al., 1998;
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Kiosses et al., 1999). Interestingly, POR1, a scaffolding pro-
tein, has been shown to be involved in both Rac-mediated
membrane ruffling, as well as ARF6-dependent cytoskeletal
rearrangements (Van Aelst et al., 1996; D’Souza-Schorey et
al., 1997). Furthermore, it is believed that the small GTPase
ARF1 plays a role in regulating recruitment of paxillin to fo-
cal adhesions and in stimulating Rho activation leading to
stress fiber formation (Norman et al., 1998). Thus, it ap-
pears that in certain cases the outcomes of Rho and ARF
family activation are linked via the use of common down-
stream effectors.
Paxillin is a multidomain focal contact adapter protein in-
volved in integrin and growth factor signaling (Turner, 2000).
The NH
 
2
 
 terminus of paxillin contains five leucine-rich do-
mains, termed LD motifs, which mediate protein–protein in-
teractions (Brown et al., 1996, 1998). The LD4 motif of pax-
illin binds a complex of proteins previously implicated in
actin cytoskeletal regulation. These include the Cdc42/Rac
guanine nucleotide exchange factor PIX, PAK, and the SH2-
SH3 adapter protein Nck. This complex is linked to paxillin
through the putative ARF-GTPase–activating protein (ARF-
GAP) paxillin kinase linker (PKL) (Turner et al., 1999),
although PAK has been suggested to also bind directly to pax-
illin via the LD4 motif (Hashimoto et al., 2001). Conse-
quently, paxillin, through these associations, may serve as a
point of integration in the control of actin cytoskeleton dy-
namics by both the Rho and ARF family GTPases.
In this study, we have evaluated the importance of the pax-
illin–PKL interaction in mediating cytoskeletal changes asso-
ciated with cell adhesion and motility. We demonstrate that
in CHO.K1 fibroblasts, perturbation of the interaction be-
tween paxillin and PKL interferes with the proper regulation
of Rac activity and induces dramatic effects on cell spreading,
morphology, and motility after plating on fibronectin.
 
Results
 
Ectopic expression of paxillin lacking the LD4 motif 
promotes cell spreading and alters cell morphology
 
The focal adhesion adapter protein paxillin participates in
the assembly of a complex of proteins involved in Rac regu-
lation of the cytoskeleton during cell spreading and migra-
tion (Turner et al., 1999). To further characterize the role of
paxillin, and specifically the LD4 motif, in controlling these
Rac-dependent processes, clonal cell lines expressing full-
length avian paxillin engineered with a deletion of the LD4
motif (paxillin
 
 
 
LD4) and full-length wild-type avian paxil-
lin (paxillin WT) were generated in CHO.K1 fibroblasts.
Fig. 1 A demonstrates the level of overexpression of both the
ectopic paxillin
 
 
 
LD4 and paxillin WT in these clonal cell
lines, as compared with the level of endogenous paxillin in
the parental CHO.K1 cells.
To assess the contribution of the paxillin LD4 motif in cell
spreading, cells were detached from tissue culture dishes and
then allowed to respread on a fibronectin substratum. At the
earliest time point (15 min), paxillin
 
 
 
LD4 cells were slightly
but reproducibly more spread, whereas all cell types were
spread to the same degree by 30 min (data not shown). How-
ever, once spread, the cells demonstrated significant differ-
 
ences in morphology at later times. At 60, 240, and 360 min
after plating, both paxillin WT and parental nontransfected
cells exhibited an angular elongated morphology (Fig. 1,
B, b, c, e, and f, and C). In contrast, 
 
 
 
60% of the
paxillin
 
 
 
LD4 cells developed multiple broad lamellipodia-
like structures (Fig. 1, B, a and d, and C). Immunofluores-
cence analysis demonstrated that the ectopically expressed
paxillin, visualized with an avian-specific paxillin antisera
(Pax1) (Turner and Miller, 1994), localized to the periphery
of these lamellipodia-like structures in small focal contacts
(Fig. 1 B, a, arrows), as well as to central focal contacts (Fig. 1
B, a, double arrows). In the paxillin WT and parental non-
transfected cells, both ectopic and endogenous paxillin were
concentrated primarily in central focal contacts and those as-
sociated with the ends of robust stress fibers (Fig. 1 B, b and
c, arrows). Many of the paxillin
 
 
 
LD4 cells also exhibited re-
traction fiber-like structures, suggesting a motile phenotype
(Fig. 1 B, a, arrowhead).
To ensure these results were not due to a clonal phenome-
non, full-length wild-type avian paxillin and wild-type avian
paxillin engineered with a deletion of LD4 were transiently
expressed in CHO.K1 cells. Analysis of these cells in spread-
ing assays on fibronectin yielded results similar to those de-
scribed above (data not shown). Since the paxillin WT and
parental nontransfected cells behaved indistinguishably dur-
ing spreading assays, paxillin WT cells were used for much
of the remaining experimentation described herein.
To determine whether this morphological change was at-
tributable solely to the absence of the paxillin LD4 motif, we
introduced a full-length wild-type avian GFP–paxillin fu-
sion (GFP–paxillin) into both paxillin
 
 
 
LD4 and paxillin
WT cells and examined the cell’s phenotype during spread-
ing on fibronectin. Although GFP–paxillin had no effect on
the morphology of paxillin WT cells, its introduction into
paxillin
 
 
 
LD4 cells reduced the generation of multiple broad
lamellipodia to 
 
 
 
20%, as compared with 
 
 
 
60% in pax-
illin
 
 
 
LD4 cells not containing GFP–paxillin (Fig. 2, B, a
and c, and C). This effect was entirely due to the reintroduc-
tion of wild-type GFP–paxillin since expression of GFP
alone did not disrupt the morphological changes observed in
paxillin
 
 
 
LD4 cells (data not shown). The above observa-
tions suggest that the LD4 motif of paxillin is involved in
the regulation of actin cytoskeletal changes that occur dur-
ing cell spreading.
 
Deletion of paxillin LD4 increases random cell motility
 
The formation of membrane ruffles and lamellipodia are
characteristics of motile cells (Mitchison and Cramer, 1996).
To test a role for paxillin’s LD4 motif in the regulation of
cell motility, paxillin
 
 
 
LD4, paxillin WT and parental non-
transfected CHO.K1 cells were plated on fibronectin and
then analyzed using time-lapse video microscopy. Interest-
ingly, paxillin
 
 
 
LD4 cells were highly active, extending mul-
tiple lamellipodia (Fig. 3 A, arrows, and B). In addition, long
retraction fiber-like processes were observed (Fig. 3 A, arrow-
heads). In contrast, paxillin WT and parental nontransfected
cells displayed little protrusive activity (Fig. 3, A and B). The
exaggerated protrusive activity of the paxillin
 
 
 
LD4 cells was
accompanied by a significant increase in the rate of random
motility of these cells over paxillin WT and parental non- 
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transfected cell populations (Fig. 3 C). To test the effects of
the deletion of paxillin LD4 motif on haptotaxis, modified
Boyden chamber migration assays were performed. In sup-
port of the time-lapse video microscopy data, paxillin
 
 
 
LD4
cells migrated at a higher rate than both paxillin WT and pa-
rental nontransfected cells (Fig. 3 D). Interestingly, overex-
pressing paxillin constructs engineered with a deletion of the
second LD motif (paxillin
 
 
 
LD2) in CHO.K1 cells did not
affect migration (Fig. 3 D). Focal adhesion kinase (FAK), a
protein implicated in cell motility, has been shown to associ-
ate with paxillin through both LD2 and LD4 (Turner and
Miller, 1994; Ilic et al., 1995; Brown et al., 1996; Cary et al.,
1996; Turner et al., 1999). This suggests that the increases in
random motility caused by deletion of the LD4 motif were
not due to the uncoupling of FAK and paxillin.
We have previously demonstrated that microinjection of a
glutathione 
 
S
 
-transferase (GST)–LD4 fusion protein into
NIH 3T3 cells inhibited cell migration into scrape wounds
 
(Turner et al., 1999). To address this potential discrepancy,
wound assays were performed with paxillin
 
 
 
LD4 and paxillin
WT cells. The ability of each cell type to close the wound was
then assessed over a 24-h time period (24h) using time-lapse
video microscopy. 24 h after wounding, the paxillin WT cells
had filled in the wound area (Fig. 3 E, d), identical to parental
CHO.K1 cells (data not shown), whereas the paxillin
 
 
 
LD4
cells were significantly retarded in their ability to close the
wound (Fig. 3 E, c). Together, these data demonstrate, that
although overexpression of paxillin
 
 
 
LD4 leads to an increase
in cell protrusive activity and random cell motility, it inhibits
persistent cell migration as assessed by wound assays.
 
The generation of broad lamellipodia-like structures
in paxillin
 
 
 
LD4 cells correlates with a prolonged 
elevation in Rac activity
 
Activation of the Rho family member Rac induces the for-
mation of lamellipodia and membrane ruffles and has been
Figure 1. Expression of paxillin LD4 
deletion generates multiple broad 
lamellipodia during cell spreading. (A) 
Immunoprecipitation using avian-spe-
cific paxillin antisera (Pax1, right) and 
Western immunoblotting of total cell ly-
sates (left) confirm the relative levels of 
paxillin, PKL, and p130
cas protein, and 
demonstrates the overexpression of 
avian paxillin in the paxillin LD4 and 
paxillin WT cells compared with paren-
tal nontransfected CHO.K1 cells. (B, a and 
d) CHO.K1 cells ectopically expressing 
avian paxillin with the deletion of LD4 
(paxillin LD4); (b and e) CHO.K1 cells 
ectopically expressing full-length wild-
type avian paxillin (paxillin WT); (c and f) 
parental nontransfected CHO.K1 cells. 
CHO.K1 cells were respread on fibronec-
tin-coated (Fn) coverslips (10  g/ml) for 
60, 240, and 360 min, and ectopic paxil-
lin (Pax1, a and b), endogenous paxillin 
(c), and actin (d–f) were examined. 
Paxillin LD4 cells exhibit a dramatic in-
crease in the generation of broad lamelli-
podia with ectopic paxillin localizing to 
the cell periphery in focal contacts (a, ar-
rows). Tail-like retraction fibers were fre-
quently observed (a, arrowhead). Double 
arrows in a show ectopic paxillin in cen-
tral focal contacts. Arrows in b and c 
show ectopic and endogenous paxillin in 
focal contacts, respectively. Images of the 
cells were captured at 240 min and are 
representative of the differences in cell 
morphology observed at the time points 
tested; i.e., 60, 240, and 360 min. (C) 
The number of cells exhibiting multiple 
broad lamellipodia (as exemplified by 
the cell pictured in B, a and d) was quan-
tified by counting  200 cells per time 
point and indicates the dramatic increase 
in these structures in paxillin LD4 cells. 
Values are the average of experiments 
performed in triplicate. 
164 The Journal of Cell Biology 
 
|
 
 
 
Volume 154, 2001
 
implicated in cell spreading and motility (Ridley et al.,
1992; Clark et al., 1998; Price et al., 1998; Rottner et al.,
1999). In paxillin
 
 
 
LD4 cells, a dramatic increase in broad
lamellipodia-like structures was observed during cell spread-
ing along with increases in cell protrusive activity and ran-
dom motility. This suggested a potentiation of Rac activity.
To determine whether or not Rac plays a role in these pro-
cesses, paxillin
 
 
 
LD4 and paxillin WT cells were detached
and allowed to spread on fibronectin. Cell lysates from these
cells were incubated with GST fusion proteins containing
the p21-binding domain of PAK, (GST–PBD), which binds
only active or GTP-bound Rac, or Cdc42 (Sander et al.,
1998). The amount of activated endogenous Rac bound was
analyzed by Western blotting using anti-Rac antibodies.
Paxillin WT cells spreading on fibronectin showed an in-
crease in Rac activity at 5 min, peaking at 15
 
 
 
min, followed
by a gradual return to baseline (Fig. 4, A and B). In contrast,
paxillin
 
 
 
LD4 cells exhibited a steady and prolonged activa-
tion of Rac that was maintained out to 360 min (Fig 4, A
and B). The Rac activation profile observed in paxillin WT
cells is similar to what has been reported for cells stimulated
with exogenous growth factors, and to the activation of PAK
during cell spreading (Price et al., 1998; Sander et al., 1999).
However, this is the first study in which the time course of
Figure 2. Reintroduction of wild-type 
paxillin into paxillin LD4 cells rescues 
the normal spreading phenotype. (A) 
Western blot analysis using GFP poly-
clonal antisera was used to confirm the 
presence of the ectopic GFP–paxillin 
protein. (B) Paxillin LD4 and paxillin 
wild-type cells were transiently trans-
fected with GFP-paxillin LD4 and sub-
jected to spreading assays on fibronectin 
for 60, 240, and 360 min, and GFP–pax-
illin transfectants were visualized by 
GFP fluorescence (a and b), and actin, 
by RITC-phalloidin (c and d). Arrows in 
c indicate paxillin LD4 cells expressing 
GFP–paxillin lacking broad lamellipo-
dia, whereas arrowheads in c demon-
strate the presence of these structuresin a 
cell lacking GFP-paxillin. Images of the 
cells were captured at the 240-min time 
point and are representative of the differ-
ences in cell morphology observed at all 
time points. (C) The number of cells ex-
hibiting multiple broad lamellipodia was 
quantified by counting  200 cells per 
time point. Values are the average of ex-
periments performed in triplicate. 
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Rac activity during cell spreading has been directly mea-
sured.
To test if the elevated and prolonged Rac activation was
responsible for the additional protrusive activity and broad
lamellipodia exhibited by the paxillin
 
 
 
LD4 cells, dominant-
negative forms of Rac (Myc-N17 Rac) were transiently
expressed in paxillin
 
 
 
LD4 and paxillin WT cells. Intro-
duction of N17 Rac into paxillin
 
 
 
LD4 cells completely
abolished the generation of the multiple broad lamellipodia-
like structures characteristic of these cells (Fig. 5, B and C).
N17 Rac also inhibited lamellipodia formation in the paxil-
lin WT cells (Fig. 5, B and C). Similarly, expression of domi-
nant-negative Cdc42, which is upstream of Rac and is criti-
cally involved in cell spreading, also severely inhibited broad
lamellipodia formation in paxillin
 
 
 
LD4 cells (Fig. 5 D)
(Ridley et al., 1992; Clark et al., 1998; Price et al., 1998).
Together, these data indicate that elevated and prolonged
Rac activation is involved in the generation of the phenotype
observed in paxillin
 
 
 
LD4 cells and that paxillin can regulate
normal Rac activity during cell spreading. In addition, delet-
ing the paxillin LD4 motif appears to prevent the normal
progression from a Rac-dependent phenotype, to an angular
elongated phenotype during cell spreading.
 
Deletion of paxillin LD4 perturbs the localization 
of endogenous PKL, but not FAK or vinculin, 
in paxillin
 
 
 
LD4 cells
 
We have previously shown that the LD4 motif of paxillin
binds to both FAK and vinculin as well as to the newly char-
acterized putative ARF-GAP protein PKL (Turner and
Miller, 1994; Brown et al., 1996; Turner et al., 1999). The
association of paxillin with PKL mediates an interaction
with a protein complex comprised of PIX/PAK/Nck, which
has been implicated in Rac-dependent cytoskeletal rear-
rangements (Manser et al., 1997; Sells et al., 1997; Ober-
meier et al., 1998; Zhao et al., 1998). The involvement
of the LD4 motif of paxillin in the signaling pathway(s)
controlling actin-driven cytoskeletal dynamics during cell
spreading and motility led us to investigate a possible role
for the interaction between paxillin and PKL in these events.
To evaluate the significance of the paxillin–PKL association,
the distribution of endogenous PKL was first determined in
paxillin
 
 
 
LD4, paxillin WT, and parental CHO.K1 cells.
Although colocalization of paxillin and PKL in focal con-
tacts was observed in paxillin WT and parental CHO.K1
cells (Fig. 6 A, b and e, c and f, respectively), the distribution
of PKL in paxillin
 
 
 
LD4 cells was almost exclusively cyto-
plasmic (Fig. 6 A, a). In contrast, the ectopic paxillin in
paxillin
 
 
 
LD4 cells was found in peripheral and central focal
contacts, as well as the cytoplasm (Fig. 6 A, d).
The failure of paxillin and PKL to colocalize in focal con-
tacts suggests a disruption of the interaction between these pro-
teins. To demonstrate this in vivo, parental CHO.K1 cells
were transiently transfected with GFP fused to either full-
length wild-type paxillin (GFP–paxillin) or paxillin
 
 
 
LD4
(GFP–paxillin
 
 
 
LD4). Cell lysates from transfected cells spread
on fibronectin for 60 min were immunoprecipitated with anti-
GFP antibody. GFP–paxillin, but not GFP–paxillin
 
 
 
LD4 was
able to precipitate endogenous PKL (Fig. 6 B).
 
Although the localization of PKL to focal contacts was dis-
rupted by the deletion of paxillin LD4, expression of this mu-
tant had no affect on the distribution of either FAK or vincu-
lin, two other focal contact proteins shown to associate with
paxillin via multiple LD motif interactions (Fig. 6 C) (Turner
and Miller, 1994; Brown et al., 1996; Turner et al., 1999).
To further demonstrate that the phenotypic changes ob-
served in paxillin
 
 
 
LD4 cells were not due to perturbation of
normal FAK function through the disruption of a paxillin–
LD4-FAK interaction, the change in FAK activity in these
cells during spreading was assessed by measuring phosphory-
lation of the FAK autophosphorylation site Y397 (Schaller
et al., 1994; Ruest et al., 2000). Parental CHO.K1, paxillin
WT, or paxillin
 
 
 
LD4 cells respread on fibronectin for the
times indicated demonstrated similar general changes in
phosphotyrosine phosphorylation levels (Fig. 6 D, top).
Moreover, immunoblotting of FAK immunoprecipitates
from these same cell lysates with FAK Y397 phosphospecific
antisera indicated equivalent FAK activation in all three cell
lines (Fig. 6 D, middle).
 
Introduction of PKL mutants defective in paxillin-binding, 
but not wild-type PKL, induce paxillin WT cells to exhibit 
a morphology characteristic of paxillin
 
 
 
LD4 cells
 
We have previously localized the binding site of PIX to the
NH
 
2
 
 terminus of PKL, and that of paxillin to the COOH
terminus (Turner et al., 1999). However, PKL contains two
putative paxillin-binding subdomains (PBSs), based on their
homology with the paxillin-binding sites of vinculin and
FAK (Wood et al., 1994; Tachibana et al., 1995; Brown et
al., 1996). To identify the PKL PBS that mediates paxillin
LD4 binding, radiolabeled full-length PKL proteins, as well
as PKL proteins containing either a deletion of PBS1 or
PBS2 (Fig. 7 A), were produced by transcription/transla-
tion-coupled reactions and used in in vitro binding assays
with GST-coupled fusion proteins, GST–PIX and GST–
LD4. Although GST–PIX was found to bind the wild-type
and both mutant PKL proteins, GST–LD4 bound to both
full-length PKL and the PBS1 deletion mutant, but no
binding was observed to the PBS2 deletion mutant (Fig. 7
B). These results identify the PBS2 region of PKL as the
paxillin-binding site.
To demonstrate the importance of the PBS2 domain of
PKL in mediating the binding to paxillin in vivo, parental
CHO.K1 cells were transiently transfected with either GFP–
PKL or GFP–PKL
 
 
 
PBS2. Cell lysates from cells spread on
fibronectin for 60 min were immunoprecipitated with anti-
GFP antibody, and the ability to coprecipitate endogenous
paxillin was analyzed. Endogenous paxillin coimmunopre-
cipitated only with full-length GFP–PKL, whereas GFP–
PKL
 
 
 
PBS2 failed to precipitate paxillin (Fig. 7 C).
To test whether PKL binding to the paxillin LD4 motif
via the PBS2 domain was necessary for normal cell spreading
both paxillin
 
 
 
LD4 and paxillin WT cells were transiently
transfected with GFP–PKL or GFP–PKL
 
 
 
PBS2 and evalu-
ated for spreading on fibronectin. Although the introduc-
tion of GFP–PKL
 
 
 
PBS2 into paxillin
 
 
 
LD4 cells had no ef-
fect on cell morphology, expression of this construct in
paxillin WT cells caused the generation of a paxillin
 
 
 
LD4- 
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like phenotype in 
 
 
 
50% of cells (Fig. 8, B and C). Expres-
sion of GFP–PKL had no effect on the morphology of either
paxillin
 
 
 
LD4 or paxillin WT cells (Fig. 8, B and C). How-
ever, although it can be seen that paxillin and PKL colocalize
in paxillin WT cells expressing GFP–PKL (Fig. 9 A, b and
f), in paxillin
 
 
 
LD4 cells expressing either GFP–PKL or
GFP–PKL
 
 
 
PBS2, PKL is cytoplasmic (Fig. 9 A, a and c),
whereas paxillin is found in focal contacts (Fig. 9 A, e and
g). In paxillin WT cells, GFP–PKL
 
 
 
PBS2 remained cyto-
plasmic (Fig. 9 A, d), whereas paxillin was found in focal
contacts (Fig. 9 A, h). Thus, the introduction of wild-type
PKL or PKL lacking the paxillin-binding site does not affect
paxillin localization. Similar effects on morphology and pax-
illin and PKL subcellular localization were also obtained by
the introduction of either GFP–PKL or GFP–PKL
 
 
 
PBS2
into parental CHO.K1 cells (data not shown).
To further address the role of the paxillin–PKL interac-
tion in the phenotypic changes observed in paxillin
 
 
 
LD4
Figure 3. Overexpression of paxillin LD4 affects the protrusive ac-
tivity and motility of cells. (A) Paxillin LD4, paxillin WT, and paren-
tal nontransfected CHO.K1 cells were plated on fibronectin (2  g/ml), 
and motility was analyzed by time-lapse video microscopy. 
Paxillin LD4 cells were much more dynamic than paxillin WT and 
parental nontransfected cells, extending multiple lamellipodia (ar-
rows). Long retraction fiber-like extensions were also observed (arrow-
head). (B) Quantification of protrusiveness demonstrates an increase 
in cell area (in  m
2) of paxillin LD4 cells, as compared with paxil-
lin WT and parental nontransfected cells. (C) Quantification of ran-
dom motility on fibronectin (2  g/ml) demonstrates an increase in 
locomotion (in  m/hr) in paxillin LD4 cells, as compared with pax-
illin WT and parental nontransfected cells. (D) Quantification of 
random motility to fibronectin (10  g/ml) reveals a striking increase 
in the percentage of paxillin LD4 cells migrating to immobilized fi-
bronectin, as compared with paxillin WT, paxillin LD2, and paren-
tal nontransfected cells. Values are the average of modified Boyden 
chamber assays performed in quadruplicate. The migration of pa-
rental nontransfected CHO.K1 cells was set to 100%, and the other 
cell types were measured against this value. (E) Scrape wound as-
says using paxillin LD4 and paxillin WT cells plated in 35-mm tis-
sue culture dishes in complete media at a confluent density and 
scored with a micropipet tip demonstrate that, although paxillin WT 
cells are able close the wound, paxillin LD4 are severely retarded 
in this capacity. The images are representative of experiments per-
formed in triplicate.Rac regulation via paxillin LD4 | West et al. 167
cells, the protrusiveness of parental CHO.K1 cells tran-
siently transfected with PKL PBS2 or cotransfected with
both wild-type avian paxillin and GFP–PKL PBS2 were
analyzed by time-lapse microscopy. Consistent with the
above results, introduction of GFP–PKL PBS2 induced a
more protrusive morphology in cells and this was enhanced
by the simultaneous expression of both wild-type paxillin
and GFP–PKL PBS2 (Fig. 9 B). This elevated protrusive
activity is reminiscent of paxillin LD4 cells (Fig. 3 B). Ex-
pression of GFP–PKL in parental CHO.K1 cells had no af-
fect on cell protrusiveness (data not shown).
Discussion
Paxillin is a multidomain focal contact adapter protein in-
volved in integrin and growth factor-mediated signaling
(Turner, 2000). In this study, we demonstrate the impor-
tance of the interaction between paxillin and PKL in con-
trolling morphologic and cytoskeletal changes associated
with cell adhesion and motility.
Cell spreading on ECM involves coordinated regulation
of the activity of various Rho family members. In particular,
previous studies using NIH3T3 cells have shown that early
spreading events are characterized by the extension of lamel-
lipodia, which correlates with a transient increase in Cdc42/
Rac-dependent PAK activity. Maximum activity is achieved
between 10 and 20 min after plating, followed by a steady
decline in kinase activity to baseline levels (Price et al.,
1998). A transient reduction in Rho activity during the ini-
tial phase of cell spreading has also been reported (Ren et al.,
1999). The decline in PAK, and presumably Cdc42/Rac ac-
tivity, is generally accompanied by the development of a
more elongated angular phenotype associated with the acti-
vation of Rho (Rottner et al., 1999; Sander et al., 1999;
Arthur et al., 2000). Our results indicate that in parental
CHO.K1 cells, or CHO.K1 cells overexpressing wild-type
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paxillin (paxillin WT), there is a similar sequence of mor-
phologic changes and time course of Rac activation/inactiva-
tion, reaching a maximum at 15 min after plating. In strik-
ing contrast, overexpression in CHO.K1 cells of a paxillin
mutant lacking the LD4 motif (paxillin LD4) resulted in a
dramatic increase in membrane activity during cell spread-
ing. This included the generation of multiple broad lamelli-
podia-like structures and enhanced membrane protrusive ac-
tivity that persisted for several hours; i.e., the cells failed to
transition to the more typical angular phenotype. Interest-
ingly, the phenotypic changes induced by the paxillin LD4
were accompanied by a prolonged elevation in Rac activity,
suggesting that paxillin, through its LD4 adapter function, is
critical for the tight regulation of Rac activity during the
spreading process.
We have previously demonstrated that the paxillin LD4
motif is capable of binding directly to several proteins in-
cluding the focal adhesion tyrosine kinase FAK, the actin-
binding protein vinculin, and more recently PKL, a putative
ARF-GAP (Turner and Miller, 1994; Brown et al., 1996;
Turner et al., 1999). The paxillin LD4 mutant protein lo-
calized as efficiently as wild-type paxillin to focal complexes
and focal contacts (Fig. 1 B), consistent with the use of the
focal contact targeting sequence within the paxillin LIM do-
mains (Brown et al., 1996). Importantly, overexpression of
the paxillin LD4 mutant failed to affect the localization to
focal contacts of either FAK or vinculin (Fig. 6 C). In con-
trast, PKL localization to these structures was lost in the
paxillin LD4-expressing cells (Fig. 6 A). This difference is
likely due to the fact that, although FAK and vinculin can
bind to additional LD motifs within the NH2 terminus of
paxillin, PKL binds exclusively to the LD4 motif (Turner
and Miller, 1994; Brown et al., 1996; Turner et al., 1999).
In addition to increased cell spreading, enhanced protru-
siveness, and multiple lamellipodia, paxillin LD4 mutant
cells exhibit long tail-like retraction fibers suggestive of
highly motile cells and/or a defect in rear release (Figs. 1 B
and 3 A). We found that these cells display an increased ran-
dom motile capacity (Fig. 3, A–D). This stimulation of mo-
tility is consistent with data demonstrating that perturbation
of the normal pathway of PAK function by expression of ei-
ther kinase-dead or constitutively active PAK mutants in-
creases basal cell motility (Sells et al., 1999). However, PAK
kinase activity primarily functions to effect directional mo-
tility (Sells et al., 1999). Previously we demonstrated that
microinjection of GST–LD4 into NIH 3T3 cells inhibited
directed migration in a scrape wound assay (Turner et al.,
1999). We confirm in this report that although deletion of
paxillin LD4 increases random motility, directional motility
as measured by scrape wound assay is profoundly attenuated
(Fig. 3 E). The existence of long retraction fibers in
paxillin LD4 mutant cells is consistent with impaired tail
release. Efficient release is necessary for cell migration (Small
et al., 1996; Horwitz and Parsons, 1999) and has been pro-
posed to require proper PAK activity (Kiosses et al., 1999).
However, in addition to mediating PKL binding, paxillin
LD4, as well as LD2, supports FAK association (Turner and
Miller, 1994; Brown et al., 1996; Turner et al., 1999). A
role for FAK in cell motility is well characterized (Ilic et al.,
1995; Cary et al., 1996; Hauck et al., 2000; Sieg et al.,
Figure 4. Rac activity is prolonged in 
paxillin LD4 cells. (A) Paxillin LD4 and 
paxillin WT cells were detached and al-
lowed to spread on fibronectin for 0, 5, 
15, 60, 240, and 360 min. At each time 
point, cell lysates were prepared, and 
then activated Rac was precipitated us-
ing GST fusion proteins of the p21-bind-
ing domain of PAK (GST–PBD). Total 
and active Rac was assessed by immuno-
blot analysis with anti-Rac monoclonal 
antibodies and revealed a gradual pro-
longed Rac activation in paxillin LD4 
cells compared with paxillin WT cells, 
which exhibit an initial rise in activity 
before returning to baseline activity. (B) 
The activation of Rac in paxillin LD4 
and paxillin WT cells during spreading 
was quantified by measuring the ratio of 
GST–PBD-bound Rac to total Rac. The t 
  0 value of paxillin WT cells was set to 
1, and all other values were measured 
against it. Values are the average of ex-
periments performed in triplicate. The 
inset depicts Rac activation in 
paxillin LD4 and paxillin WT cells be-
tween 0 and 70 min.Rac regulation via paxillin LD4 | West et al. 169
2000, 1999; Klingbeil et al., 2001). Further, a FAK–paxil-
lin interaction has been implicated directly and indirectly
(as measured by paxillin tyrosine phosphorylation) in cell
spreading, neurite outgrowth, and cell migration (Ivankovic-
Dikic et al., 2000). In addition, expression of the PKL-
related protein GIT1 promotes cell motility in a FAK- and
paxillin-dependent manner (Zhao et al., 2000). It has been
proposed that GIT1 increases cell motility by paxillin-
dependent recruitment to focal contacts where it causes loss
of paxillin to increase focal complex dynamics, and through
PIX and FAK binding, activates Rac and antagonizes Rho,
respectively (Zhao et al., 2000). Importantly, PKL, unlike
GIT1, does not contain the Spa2 homology domain that
mediates FAK binding (Turner et al., 1999; Zhao et al.,
2000). In addition, neither a change in FAK localization or
activity was apparent in paxillin LD4 cells (Fig. 6, C and
D, respectively), nor was any defect in motility observed
with paxillin LD2 mutant cells (Fig. 3 D). These data com-
bined with the demonstration that PKL PBS2 recapitulates
the paxillin LD4 phenotype (Figs. 8 and 9) are consistent
with a role for paxillin–PKL in regulating PAK function.
Moreover, these data indicate a direct PAK–paxillin interac-
tion (Hashimoto et al., 2001) cannot compensate for the
perturbation of the PKL–paxillin connection. Thus, inter-
ference with the normal physiologic paxillin–PKL–PIX–
PAK cascade causes the profound phenotypic alterations we
report in this study.
Although the role for FAK in cell motility is well charac-
terized, the precise role for paxillin is less clear. Paxillin, and
its tyrosine phosphorylation, has been implicated in the reg-
ulation of cell migration (Liu et al., 1999; Riedy et al., 1999;
Salgia et al., 1999; Turner et al., 1999; Ito et al., 2000; Na-
kamura et al., 2000; Petit et al., 2000; Yano et al., 2000).
However, overexpression of wild-type paxillin   has been
shown to stimulate (Nakamura et al., 2000; Yano et al.,
2000), inhibit (Salgia et al., 1999), and also fail to affect cell
motility (Petit et al., 2000). These apparent discrepancies
may be due to differences in cell systems and assays, but also
likely point to the complex interactions that occur between
paxillin and its binding partners that serve to regulate cell
motility. That notwithstanding, this study demonstrates
that the interaction between paxillin and PKL is critical in
regulating Rac-dependent cell shape change and motility.
How might the interaction between paxillin and PKL reg-
ulate this cytoskeletal reorganization and Rac activity? Paxil-
lin is linked, via PKL, to a PIX–PAK–Nck complex (Turner
et al., 1999), each member of which is critically involved in
the regulation of actin cytoskeleton dynamics. The precise
temporal activation and spatial distribution of these proteins
has been shown to be critical for proper Rac and Cdc42 sig-
naling to the cytoskeleton (Bokoch et al., 1996; Galisteo et
al., 1996; Lu et al., 1997; Manser et al., 1997, 1998; Ba-
grodia et al., 1998; Frost et al., 1998; Obermeier et al.,
1998; Sells et al., 1999, 1997). A major means of regulating
PAK function is through its restricted capacity to localize to
focal complexes. Wild-type PAK normally maintains a dif-
fuse cytoplasmic localization and transiently translocates to
focal contacts stimulated by active Cdc42 or Rac, but not
RhoA (Manser et al., 1997). The primary mechanism by
which PAK localizes to focal contacts is not clear. However,
Figure 5. Introduction of dominant-negative forms of Rac and 
Cdc42 abrogate the morphological changes observed in 
paxillin LD4 cells. (A) Western blot analysis using monoclonal 
anti-Myc antibodies was used to confirm the presence of the ectopic 
Myc-tagged N17 Rac in paxilin LD4 and wild-type paxillin-trans-
fected cells. (B) Paxillin LD4 and paxillin WT cells were transiently 
transfected with either Myc-tagged forms of dominant-negative Rac 
(N17 Rac) or dominant-negative Cdc42 (N17 Cdc42), detached and 
then allowed to spread on fibronectin for 60, 240, and 360 min. 
N17 Rac–transfected cells were then visualized by anti-Myc (a and 
b) and actin by RITC-phalloidin (c and d) and demonstrate that the 
introduction N17 Rac is able to completely inhibit the formation of 
multiple broad lamellipodia in paxillin LD4 cells. Images of the 
cells were captured at the 240-min time point and are representa-
tive of the differences in cell morphology observed at all time 
points. (C and D) Quantification of the ability of N17 Rac and N17 
Cdc42 to abolish the morphological changes observed in 
paxillin LD4 cells demonstrates that both Rho family small GT-
Pases affect the generation of multiple broad lamellipodia in 
paxillin LD4 cells.  200 cells were counted per time point, and 
values are the average of experiments performed in duplicate.170 The Journal of Cell Biology | Volume 154, 2001
Figure 6. Deletion of paxillin LD4 af-
fects endogenous PKL localization and 
paxillin–PKL association in vivo, but not 
FAK or vinculin localization or FAK ac-
tivity. (A) Paxillin LD4, paxillin WT, 
and parental nontransfected CHO.K1 
cells spread on fibronectin were pro-
cessed for indirect immunofluorescence 
using antipaxillin antisera (Pax1) (d and 
e), phosphospecific Y118 paxillin anti-
sera (f), and anti-PKL antibodies (a–c), 
which demonstrates the colocalization 
of paxillin and endogenous PKL in focal 
contacts in paxillin WT and parental 
nontransfected cells (b and e, c and f). In 
contrast, in paxillin LD4 cells, ectopic 
paxillin was found in focal contacts, 
whereas the endogenous PKL distribu-
tion was cytoplasmic (a and d, respec-
tively). (B) Parental CHO.K1 cells were 
transiently transfected with either GFP–
paxillin or GFP–paxillin LD4, detached 
from tissue culture dishes, and respread 
on fibronectin for 60 min. Coimmuno-
precipitation assays were then performed 
followed by Western blot analysis and 
demonstrate that, although GFP–paxil-
lin is capable of precipitating endoge-
nous PKL, GFP–paxillin LD4 does not. 
(C) Paxillin LD4 cells spread on fi-
bronectin were processed for indirect 
immunofluorescence using either anti-
FAK (c), or antivinculin antibodies (d) 
and antipaxillin antisera (Pax1) (a and b). 
Arrowheads in a and b and arrows in c 
and d indicate that the deletion of paxil-
lin LD4 does not affect the localization 
of these other paxillin-binding partners. 
(D) Parental nontransfected CHO.K1, 
paxillin WT, and paxillin LD4 cells 
were spread on fibronectin for 0, 20, 
and 120 min, and FAK was immunopre-
cipitated from lysates derived from these 
cells. Immunoblot analysis of cell lysates 
with antiphosphotyrosine antibody and 
of FAK immunoprecipitates with phos-
phospecific Y397 FAK antisera demon-
strates equivalent FAK activation in the 
three cell lines tested.
overexpression of either PAK mutants (G191 and A192)
that cannot bind PIX or PIX SH3 mutants that can no
longer bind PAK prevent the recruitment of PAK to
G12VCdc42 focal contacts (Manser et al., 1998). Our pre-
vious results suggest that PIX may be targeted to these sites
through an interaction with PKL (Turner et al., 1999). In
fact, we have found that PAK localization to focal contacts is
entirely dependent on the precise interaction between paxil-
lin and PKL (unpublished data).
Paxillin–PKL-mediated localization of PIX and PAK to
focal contacts may be essential for the proper function of
PAK as an upstream regulator of Rac (Obermeier et al.,
1998). It had been suggested that PAK and an as yet uniden-
tified 90-kD protein (PKL?) may regulate PIX activity
(Obermeier et al., 1998). Subsequent work has confirmed
that both PAK membrane targeting and PAK binding to
PIX increases PIX GEF activity towards Rac (Obermeier et
al., 1998). Furthermore, overexpression of  PIX produced
active Rac-like changes in cell morphology presumably
through increased GEF activity (Manser et al., 1998). It is
not yet known if PKL binding to PIX influences GEF activ-
ity directly, although it is plausible that improper localiza-
tion and assembly of a PKL–PIX–PAK complex in the con-
text of paxillin LD4 leads to aberrant Rac activity.
Finally, the ability of Rac to control actin cytoskeletal dy-
namics has been linked to its activation via translocation to
the membrane (Bokoch and Knaus, 1994; Michaely et al.,
1999; Kraynov et al., 2000). This process of Rac membrane
localization is believed to be under the control of the ARF
family of proteins, in particular ARF6 (Radhakrishna et al.,Rac regulation via paxillin LD4 | West et al. 171
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1999; Zhang et al., 1999; Al-Awar et al., 2000; Boshans et
al., 2000). Several groups have recently demonstrated that
overexpression of ARF-GAP mutants of the ASAP/PAP /
PKL families resulted in marked effects on cell morphology
(Di Cesare et al., 2000; Kondo et al., 2000; Randazzo et al.,
2000). In light of the ability of the PKL PBS2 mutant to al-
ter cell morphology, it is interesting to speculate that mislo-
calization of a PKL–PIX–PAK complex may indirectly result
in the maintenance of ARF6 activity at the plasma mem-
brane and the sustained recruitment and activation of Rac,
conceivably through an inability to control the nucleotide
state of ARF6 via PKL–ARF–GAP activity.
In conclusion, our observations demonstrate that proper
paxillin adapter function is critical to the regulation of the ac-
tin cytoskeletal changes that accompany integrin engagement
with the ECM, and subsequent cell spreading and motility.
This involvement is a result of paxillin’s ability to associate
with the PKL–ARF–GAP via the LD4 motif, and entails the
modulation of Rac activity. Thus, paxillin’s ability to influ-
ence Rac activation through PKL binding conceivably places
paxillin at a junction between Rho- and ARF-family–medi-
ated changes in the actin cytoskeleton. Future investigation
will be aimed at elucidating how paxillin, PKL, and their as-
sociated proteins act in concert to regulate these processes.
Materials and methods
Cell culture and transfection
CHO.K1 cells were cultured in modified Ham’s F-12 (Mediatech, Inc.)
supplemented with 10% (vol/vol) heat-inactivated, certified FBS (Summit
Biotechnologies), 50 U/ml penicillin, and 50  g/ml streptomycin (Sigma-
Aldrich) at 37 C in a humidified chamber with 5% CO2.
CHO.K1 cells expressing full-length wild-type avian paxillin (paxillin
WT), wild-type paxillin engineered with a deletion of LD4 (amino acids
263–282) (paxillin LD4), or wild-type paxillin engineered with a deletion
of LD2 (amino acids 141–160) (paxillin LD2) was generated as previously
described (Brown et al., 1996; Riedy et al., 1999b). Clonal paxillin LD4,
paxillin LD2, and paxillin WT cell lines were maintained in the presence
of 100  g/ml G418. Transient transfections of paxillin LD4 and paxillin
WT clonal cell lines, as well as parental CHO.K1 cells, were performed us-
ing lipofectamine (GIBCO BRL). Plasmids used in this study include GFP
fused to full-length wild-type avian paxillin  , (GFP–paxillin), wild-type
paxillin engineered with a deletion of LD4 (amino acids 263–282), GFP–
paxillin LD4 full-length wild-type PKL (GFP–PKL), PKL containing a dele-
tion of the second paxillin-binding subdomain (PBS2) (amino acids 643–
679) (GFP–PKL PBS2), Myc-tagged N17 Rac, and N17 Cdc42 (gifts from
Dr. Marc Symons, Picower Institute for Molecular Research, Manhasset,
NY). Ectopic expression was confirmed by indirect immunofluorescent
analysis as described elsewhere (Turner and Miller, 1994).
Immunofluorescence microscopy
For immunofluorescence of endogenous PKL, cells were plated on fi-
bronectin-coated 13-mm glass coverslips in serum-free media for the times
described in the spreading assays. Cells were then fixed for 8 min in PBS
containing 3.7% formaldehyde, washed in 20 mM Tris-HCl, pH 7.6, 150
mM NaCl, 0.01% NaN3 (TBS), permeabilized in TBS containing 0.2% Tri-
ton X-100 (Sigma-Aldrich), and processed as previously described (Nikol-
opoulos and Turner, 2000). Photographs were taken using a ZEISS Axio-
phot photomicroscope equipped with epifluorescence illumination using
either T-max 400 film (Eastman Kodak Co.), or a SPOT™
 RT slider camera
(Diagnostic Instruments). Images were scanned using Coolscan II™ (East-
man Kodak Co.) and processed using Adobe
® Photoshop™ v3.0.5 or
SPOT™ RT software v3.0 (Diagnostic Instruments).
Antibodies used in this study include avian-specific antipaxillin poly-
clonal antibody (Pax1), which has been described previously (Turner and
Miller, 1994). Other antibodies used were antipaxillin (clone 349), anti-PKL
(clone 13, generated in collaboration with Transduction Labs using a GST–
PKL [amino acids 140–472] fusion protein as an antigen), anti-Rac (clone
102) anti-p130
cas (clone 21), and anti-FAK (clone 77) monoclonal antibod-
ies (Transduction Labs), antivinculin (Vin 11-5) monoclonal antibody
(Sigma-Aldrich), anti-phosphoY118 paxillin and anti-phosphoY397 FAK
polyclonal antibodies (Biosource International), and anti-GFP polyclonal
antibody (a gift from Dr. Pam Silver, Dana Farber Institute, Boston, MA).
The anti-Myc monoclonal antibody (9E10) developed by Dr. J. Michael
Bishop (University of California at San Francisco, San Francisco, CA) was
obtained from the Developmental Studies Hybridoma Bank maintained by
the University of Iowa, Department of Biological Sciences, Iowa City, IA.
Spreading and motility assays
Cells were removed from tissue culture dishes by washing the cells once
with PBS containing 1 mM EDTA, followed by incubation for 3–5 min at
37 C with 0.2 ml trypsin-EDTA (Sigma-Aldrich) in 1 ml PBS (1 mM) EDTA.
Cells were harvested and then washed twice with complete Ham’s F-12
media (see above) containing 10  g/ml soybean trypsin inhibitor (Sigma-
Aldrich), and once with serum-free Ham’s F-12 containing 10  g/ml soy-
bean trypsin inhibitor, and 1.1   10
5 cells were placed on a rocker in suspen-172 The Journal of Cell Biology | Volume 154, 2001
sion for 1 h at 37 C in serum-free media containing 1% BSA. Cells were re-
plated on fibronectin-coated (10  g/ml; Sigma-Aldrich) coverslips in serum-
free media and then processed for indirect immunofluorescence. For tran-
siently transfected cells, assays were performed 15–18 h after transfection.
Modified Boyden chamber migration assays were performed as previ-
ously described (Riedy et al., 1999a). Wound Assays were performed as
follows. In brief, 2.5   10
5 cells were plated on 35-mm tissue culture dishes
for 12 h at 37 C in complete media. Scrape wounds were generated in the
confluent cell monolayers using a micropipet tip. Cells were then washed
extensively and refed complete media. Phase–contrast images of the cells
were taken at 0 h (t   0) and 24 h (t   24 h) after wounding using a Nikon
Eclipse TE-300 microscope equipped with a 40  objective lens and a
SPOT™ RT Monochrome camera (Diagnostic Instruments). The images
were processed using SPOT™
 RT Software v3.0 (Diagnostic Instruments).
Time-lapse videomicroscopy was performed as previously described
(Huttenlocher et al., 1998). In brief, cells were plated in serum-free phenol
red–free CCM1 medium on fibronectin-coated plates for 1 h at 37 C and
then placed on a 37 C heated stage. Phase–contrast images were acquired
with a Nikon TE-200 inverted microscope fitted with a charge-coupled de-
vice camera (DAGE MT1). The images were taken using a 10  objective at
5-min intervals for 5–6 hours and organized into time-lapse movies using
the NIH Image software. For immunofluorescence studies, a Nikon TE-300
inverted microscope with a Hamamatsu OrcaII cooled charge-coupled de-
vice camera (Hamamatsu-City, Japan) was used. The microscope was also
equipped with a Ludl Electronic Products motorized XYZ stage and heat-
ing insert. Time-lapse images were acquired with 10  objective using the
ISee software (Inovision). At the end of filming, fields were observed by im-
munofluorescence of GFP using a 40  objective to identify transfected
cells whereupon images were analyzed using NIH Image software. For mi-
gration speed, the cell centroid was tracked and the average speed for the
cell determined by computing the average net displacement of the cell
centroid divided by the time interval at each time point. For protrusiveness
Figure 7. Characterization of the pax-
illin-binding site on PKL. (A) Schematic 
representations of full-length wild-type 
(PKL), deletion of PBS1 (PKL PBS1), and 
deletion of PBS2 (PKL PBS2) PKL pro-
teins, respectively. (B) Radiolabeled 
wild-type PKL proteins and PKL protein 
containing either a deletion of PBS1 or 
PBS2 were produced by transcription/
translation-coupled reactions and used 
in in vitro binding assays with GST–PIX 
or GST–LD4 to identify PBS2 as the pax-
illin-binding site on PKL. PIX binding to 
PKL was unaffected by either deletion. 
(C) Parental CHO.K1 cells were tran-
siently transfected with either GFP–PKL 
or GFP–PKL PBS2, detached from tissue 
culture dishes, and respread on fibronec-
tin for 60 min. Coimmunoprecipitation 
assays were then performed followed by 
Western blot analysis and demonstrate 
that GFP–PKL is capable of associating 
with paxillin in vivo, whereas GFP–
PKL PBS2 is not. Immunoblot analysis 
with an antibody to p130
cas was used to 
demonstrate the specificity of PKL–paxil-
lin interaction.Rac regulation via paxillin LD4 | West et al. 173
analysis, cells were outlined at two time points separated by 10 min; the
two images were thresholded and then subtracted to estimate the new
area. The area measurements were calibrated using a micrometer scale.
Cell lysate preparation, immunoprecipitation, 
and Western immunoblotting
Cell lysates were prepared using assay-specific lysis buffers: (a) standard
lysis buffer (150 mM NaCl, 10 mM Tris-HCl, pH 7.6, 1 mM EDTA, 1.0%
Triton X-100, and 0.1% sodium deoxycholic acid with 1 mM PMSF and 10
 g/ml leupeptin [Sigma-Aldrich]); (b) coimmunoprecipitation lysis buffer
(10 mM Tris-HCl, pH 7.6, 50 mM NaCl, 1% NP-40 [Sigma-Aldrich] and
10% glycerol [Sigma-Aldrich]); and (c) denaturing lysis buffer for FAK as-
say (1% SDS, 1% Triton-X 100, 0.1% sodium deoxycholic acid, 20 mM
Hepes, pH 7.4, 150 mM NaCl, 2.5 mM EDTA, 10% glycerol, 1 mM PMSF,
10  g/ml leupeptin, and phosphatase inhibitors [25 mM NaF, 25 mM
 -glycerophosphate, 2 mM sodium pyrophosphate, 1 mM Na3VO4, 1 mM
p-nitrophenylphosphate; Sigma-Aldrich]). Cell lysates were cleared of in-
soluble material by centrifugation at 14,000 g at 4 C for 10 min. Protein
concentrations were determined using the Dc™ protein assay (Bio-Rad
Laboratories). Immunoprecipitation was performed by incubating the ap-
propriate primary antibody and protein A/G PLUS-agarose (Santa Cruz
Biotechnology) with cell lysate (for standard or denaturing immunoprecip-
itation, 200–300  g of protein was used; for coimmunoprecipitation, 800–
1,000  g of protein was used) for 1–2 h at 4 C, rotating. Protein from de-
tergent-soluble cell lysates (for cell lysates, 20–30  g of protein was mixed
1:1 with 2  SDS-PAGE loading buffer) and immunoprecipitates were sep-
arated by SDS-PAGE using 10% polyacrylamide gels and transferred to Im-
mobilon-NC (Millipore). Western immunoblotting analysis using the
appropriate primary antibodies, followed by incubation with either anti–
mouse or –rabbit secondary antibodies conjugated to horseradish per-
oxidase (Bio-Rad Laboratories) was performed to detect the proteins of in-
terest. Chemiluminescence was used to visualize the specific proteins
(Amersham Pharmacia Biotech) by exposure to blue-sensitive autoradio-
graphic film (Marsh Bio Products, Inc.).
GST fusion protein binding assays
GST fusion proteins of  PIX (a gift from Dr. R. Cerione, Cornell University,
Ithaca, NY) and paxillin LD4 motif were expressed in Escherichia coli
(DH5 ) and purified on glutathione–agarose beads as previously described
(Turner and Miller, 1994; Riedy et al., 1999b; Turner et al., 1999). Radio-
labeled full-length PKL and PKL deletion mutants of either PBS1 (amino ac-
ids 119–155) or PBS2 (amino acids 643–679) were generated by coupled
transcription/translation reaction in a cell-free reticulocyte lysate system
(TNT and Promega) as previously described (Nikolopoulos and Turner,
2000; Turner et al., 1999).
Rac activation assays were a modified version of that designed by Ren
et al. (1999) using a GST fusion protein containing the p21-binding do-
main of PAK (GST–PBD) (a gift from Dr. R. Cerione). Immunodetection of
total and active Rac was performed using Rac-specific antisera (Transduc-
tion Labs). Densitometry analysis was performed on a Macintosh computer
Figure 8. Introduction of PKL PBS2 
mutant recapitulates the paxillin LD4 
phenotype in paxillin wild-type cells. (A) 
Western blot analysis using GFP poly-
clonal antisera was used to confirm the 
presence of the ectopic GFP–PKL and 
PKL PBS2 after transient transfection of 
these constructs into paxillin LD4 and 
paxillin WT cells. (B) Paxillin LD4 and 
paxillin WT cells were transiently trans-
fected separately with GFP–PKL or GFP–
PKL PBS2, detached, and subjected to 
spreading assays on fibronectin for 60, 
240, and 360 min. Transfected cells 
were then visualized by GFP fluores-
cence (a–d) and actin by RITC-phalloidin 
(e–h) and demonstrate that the introduc-
tion of PKL PBS2 into paxillin WT cells 
causes a transition to a paxillin LD4-like 
morphology. Arrow and arrowhead in f 
and h, respectively, demonstrate the lack 
of effect GFP–PKL has on paxillin WT 
cells, compared with the generation of 
broad lamellipodia induced by introduc-
tion of GFP–PKL PBS2. The double arrow 
in h indicates the presence of retraction fi-
ber–like extensions in paxillin WT cells 
expressing GFP–PKL PBS2, similar to 
those observed in paxillin LD4 cells. 
Images of the cells were taken from the 
240-min time point and are representa-
tive of the differences in cell morphol-
ogy observed at all time points. (C) 
Quantification of morphological change 
was assessed by counting  200 cells per 
time point and demonstrate that the in-
troduction of GFP–PKL PBS2 into
paxillin WT cells recapitulates the 
paxillin LD4 phenotype, whereas GFP–
PKL has relatively no affect. Values are 
the average of experiments performed in 
triplicate.174 The Journal of Cell Biology | Volume 154, 2001
using the public domain NIH Image program (developed at the National
Institutes of Health and available at http://rsb.info.nih.gov/nih-image). The
amount of PBD-bound Rac was normalized to the total amount of Rac in
the lysates for comparison of Rac activity in different samples. Depending
on the different cell types used (either paxillin LD4 or paxillin WT cells),
the PBD-bound Rac accounts for  0.4–3.2% of total Rac.
The authors would like to thank Dr. Scott Blystone, Mr. Dave Terfera, Mr.
Michael Curtis, and Ms. Donna Webb for helpful comments and critical
reading of the manuscript, and Mr. Brian Bouverat for expert technical as-
sistance. 
This work was supported by National Institutes of Health grants GM
47607 (C.E. Turner) and GM23244 (A.F. Horwitz), and a Grant-in-Aid
from the American Heart Association (C.E. Turner).
Submitted: 12 January 2001
Revised: 20 April 2001
Accepted: 24 May 2001
References
Al-Awar, O., H. Radhakrishna, N.N. Powell, and J.G. Donaldson. 2000. Separa-
tion of membrane trafficking and actin remodeling functions of ARF6 with
an effector domain mutant. Mol. Cell. Biol. 20:5998–6007.
Arthur, W.T., L.A. Petch, and K. Burridge. 2000. Integrin engagement suppresses
RhoA activity via a c-Src-dependent mechanism. Curr. Biol. 10:719–722.
Bagrodia, S., S.J. Taylor, K.A. Jordon, L. Van Aelst, and R.A. Cerione. 1998. A
novel regulator of p21-activated kinases. J. Biol. Chem. 273:23633–23636.
Bishop, A.L., and A. Hall. 2000. Rho GTPases and their effector proteins. Bio-
chem. J. 348:241–255.
Bokoch, G.M., and U.G. Knaus. 1994. Ras-related GTP-binding proteins and leu-
kocyte signal transduction. Curr. Opin. Hematol. 1:53–60.
Bokoch, G.M., Y. Wang, B.P. Bohl, M.A. Sells, L.A. Quilliam, and U.G. Knaus.
1996. Interaction of the Nck adapter protein with p21-activated kinase
(PAK1). J. Biol. Chem. 271:25746–25749.
Boshans, R.L., S. Szanto, L. van Aelst, and C. D’Souza-Schorey. 2000. ADP-ribo-
sylation factor 6 regulates actin cytoskeleton remodeling in coordination
with Rac1 and RhoA. Mol. Cell. Biol. 20:3685–3694.
Brown, M.C., J.A. Perrotta, and C.E. Turner. 1996. Identification of LIM3 as the
principal determinant of paxillin focal adhesion localization and character-
ization of a novel motif on paxillin directing vinculin and focal adhesion ki-
nase binding. J. Cell Biol. 135:1109–1123.
Brown, M.C., M.S. Curtis, and C.E. Turner. 1998. Paxillin LD motifs may define
a new family of protein recognition domains. Nat. Struct. Biol. 5:677–678.
Burridge, K., and M. Chrzanowska-Wodnicka. 1996. Focal adhesions, contractil-
ity, and signaling. Annu. Rev. Cell Dev. Biol. 12:463–518.
Cary, L.A., J.F. Chang, and J.L. Guan. 1996. Stimulation of cell migration by
overexpression of focal adhesion kinase and its association with Src and Fyn.
J. Cell Sci. 109:1787–1794.
Clark, E.A., W.G. King, J.S. Brugge, M. Symons, and R.O. Hynes. 1998. Inte-
grin-mediated signals regulated by members of the rho family of GTPases. J.
Cell Biol. 142:573–586.
D’Souza-Schorey, C., R.L. Boshans, M. McDonough, P.D. Stahl, and L. Van
Aelst. 1997. A role for POR1, a Rac1-interacting protein, in ARF6-mediated
cytoskeletal rearrangements. EMBO J. 16:5445–5454.
Di Cesare, A., S. Paris, C. Albertinazzi, S. Dariozzi, J. Andersen, M. Mann, R.
Longhi, and I. de Curtis. 2000. p95-APP1 links membrane transport to
Rac-mediated reorganization of actin. Nat. Cell Biol. 2:521–530.
Frost, J.A., A. Khokhlatchev, S. Stippec, M.A. White, and M.H. Cobb. 1998. Dif-
ferential effects of PAK1-activating mutations reveal activity-dependent and
-independent effects on cytoskeletal regulation. J. Biol. Chem. 273:28191–
28198.
Galisteo, M.L., J. Chernoff, Y.C. Su, E.Y. Skolnik, and J. Schlessinger. 1996. The
adaptor protein Nck links receptor tyrosine kinases with the serine-threo-
nine kinase Pak1. J. Biol. Chem. 271:20997–21000.
Hall, A. 1994. Small GTP-binding proteins and the regulation of the actin cyto-
skeleton. Annu. Rev. Cell Biol. 10:31–54.
Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science. 279:509–514.
Hashimoto, S., A. Tsubouchi, Y. Mazaki, and H. Sabe. 2001. Interaction of paxil-
lin with p21-activated kinase (PAK). Association of paxillin   with the ki-
Figure 9. Introduction of PKL and 
PKL PBS2 mutants does not affect paxil-
lin localization to focal contacts, but 
PKL PBS2 does affect cell protrusiveness. 
(A) Paxillin LD4 and paxillin WT cells 
were transiently transfected separately 
with GFP–PKL or GFP–PKL PBS2, de-
tached, and subjected to spreading assays 
on fibronectin for 60, 240, and 360 min. 
Transfected cells were then visualized by 
GFP fluorescence (a–d) and ectopic paxil-
lin by Pax1 immunofluorescence (e–h). 
Immunofluorescence analysis demon-
strates that the introduction of GFP–PKL 
and GFP–PKL PBS2 into paxillin LD4 
and paxillin WT cells does not affect 
paxillin localization to focal contacts. 
Images of the cells were captured at the 
240-min time point and are representa-
tive of the differences in cell morphol-
ogy observed at all time points. (B) 
Quantification of protrusiveness demon-
strates an increase in cell area ( m
2) of 
CHO.K1 cells transfected with 
PKL PBS2 (left), as compared with pa-
rental nontransfected cells (Fig. 3 B, bot-
tom). This observed increase in cell area 
is elevated by the cointroduction of pax-
illin and PKL PBS2 (right).Rac regulation via paxillin LD4 | West et al. 175
nase-inactive and the Cdc42-activated forms of PAK3. J. Biol. Chem. 276:
6037–6045.
Hauck, C.R., D.A. Hsia, and D.D. Schlaepfer. 2000. Focal adhesion kinase facili-
tates platelet-derived growth factor-BB-stimulated ERK2 activation required
for chemotaxis migration of vascular smooth muscle cells. J. Biol. Chem.
275:41092–41099.
Horwitz, A.R., and J.T. Parsons. 1999. Cell migration—movin’ on. Science. 286:
1102–1103.
Hotchin, N.A., and A. Hall. 1995. The assembly of integrin adhesion complexes
requires both extracellular matrix and intracellular rho/rac GTPases. J. Cell
Biol. 131:1857–1865.
Huttenlocher, A., M. Lakonishok, M. Kinder, S. Wu, T. Truong, K.A. Knudsen,
and A.F. Horwitz. 1998. Integrin and cadherin synergy regulates contact in-
hibition of migration and motile activity. J. Cell Biol. 141:515–526.
Ilic, D., Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue, N. Nakatsuji, S. Nomura,
J. Fujimoto, M. Okada, and T. Yamamoto. 1995. Reduced cell motility and
enhanced focal adhesion contact formation in cells from FAK-deficient
mice. Nature. 377:539–544.
Ito, A., T.R. Kataoka, M. Watanabe, K. Nishiyama, Y. Mazaki, H. Sabe, Y. Kita-
mura, and H. Nojima. 2000. A truncated isoform of the PP2A B56 subunit
promotes cell motility through paxillin phosphorylation. EMBO J. 19:562–
571.
Ivankovic-Dikic, I., E. Gronroos, A. Blaukat, B.U. Barth, and I. Dikic. 2000. Pyk2
and FAK regulate neurite outgrowth induced by growth factors and inte-
grins. Nat. Cell Biol. 2:574–581.
Kiosses, W.B., R.H. Daniels, C. Otey, G.M. Bokoch, and M.A. Schwartz. 1999. A
role for p21-activated kinase in endothelial cell migration. J. Cell Biol. 147:
831–844.
Klingbeil, C.K., C.R. Hauck, D.A. Hsia, K.C. Jones, S.R. Reider, and D.D.
Schlaepfer. 2001. Targeting Pyk2 to  1-integrin–containing focal contacts
rescues fibronectin-stimulated signaling and haptotactic motility defects of
focal adhesion kinase-null cells. J. Cell Biol. 152:97–110.
Knaus, U.G., and G.M. Bokoch. 1998. The p21Rac/Cdc42-activated kinases
(PAKs). Int. J. Biochem. Cell Biol. 30:857–862.
Kondo, A., S. Hashimoto, H. Yano, K. Nagayama, Y. Mazaki, and H. Sabe. 2000.
A new paxillin-binding protein, PAG3/Pap /KIAA0400, bearing an ADP-
ribosylation factor GTPase-activating protein activity, is involved in paxillin
recruitment to focal adhesions and cell migration. Mol. Biol. Cell. 11:1315–
1327.
Kraynov, V.S., C. Chamberlain, G.M. Bokoch, M.A. Schwartz, S. Slabaugh, and
K.M. Hahn. 2000. Localized rac activation dynamics visualized in living
cells. Science. 290:333–337.
Liu, S., S.M. Thomas, D.G. Woodside, D.M. Rose, W.B. Kiosses, M. Pfaff, and
M.H. Ginsberg. 1999. Binding of paxillin to  4 integrins modifies integrin-
dependent biological responses. Nature. 402:676–681.
Lu, W., S. Katz, R. Gupta, and B.J. Mayer. 1997. Activation of Pak by membrane
localization mediated by an SH3 domain from the adaptor protein Nck.
Curr. Biol. 7:85–94.
Manser, E., T. Leung, H. Salihuddin, Z.S. Zhao, and L. Lim. 1994. A brain serine/
threonine protein kinase activated by Cdc42 and Rac1. Nature. 367:40–46.
Manser, E., H.Y. Huang, T.H. Loo, X.Q. Chen, J.M. Dong, T. Leung, and L.
Lim. 1997. Expression of constitutively active  -PAK reveals effects of the
kinase on actin and focal complexes. Mol. Cell. Biol. 17:1129–1143.
Manser, E., T.H. Loo, C.G. Koh, Z.S. Zhao, X.Q. Chen, L. Tan, I. Tan, T. Le-
ung, and L. Lim. 1998. PAK kinases are directly coupled to the PIX family
of nucleotide exchange factors. Mol. Cell. 1:183–192.
Martin, G.A., G. Bollag, F. McCormick, and A. Abo. 1995. A novel serine kinase
activated by rac1/CDC42Hs-dependent autophosphorylation is related to
PAK65 and STE20. EMBO J. 14:4385.
Michaely, P.A., C. Mineo, Y.S. Ying, and R.G. Anderson. 1999. Polarized distri-
bution of endogenous Rac1 and RhoA at the cell surface. J. Biol. Chem. 274:
21430–21436.
Mitchison, T.J., and L.P. Cramer. 1996. Actin-based cell motility and cell locomo-
tion. Cell. 84:371–379.
Nakamura, K., H. Yano, H. Uchida, S. Hashimoto, E. Schaefer, and H. Sabe.
2000. Tyrosine phosphorylation of paxillin   is involved in temporospatial
regulation of paxillin-containing focal adhesion formation and F-actin orga-
nization in motile cells. J. Biol. Chem. 275:27155–27164.
Nikolopoulos, S.N., and C.E. Turner. 2000. Actopaxin: a new focal adhesion pro-
tein that binds paxillin LD motifs and actin and regulates cell adhesion. J.
Cell Biol. 151:1435–1448
Nobes, C.D., and A. Hall. 1995. Rho, rac, and cdc42 GTPases regulate the assem-
bly of multimolecular focal complexes associated with actin stress fibers,
lamellipodia, and filopodia. Cell. 81:53–62.
Norman, J.C., D. Jones, S.T. Barry, M.R. Holt, S. Cockcroft, and D.R. Critchley.
1998. ARF1 mediates paxillin recruitment to focal adhesions and potentiates
Rho-stimulated stress fiber formation in intact and permeabilized Swiss 3T3
fibroblasts. J. Cell Biol. 143:1981–1995.
Obermeier, A., S. Ahmed, E. Manser, S.C. Yen, C. Hall, and L. Lim. 1998. PAK
promotes morphological changes by acting upstream of Rac. EMBO J. 17:
4328–4339.
Petit, V., B. Boyer, D. Lentz, C.E. Turner, J.P. Thiery, and A.M. Valles. 2000.
Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell
migration through an association with CRK in NBT-II cells. J. Cell Biol.
148:957–970.
Price, L.S., J. Leng, M.A. Schwartz, and G.M. Bokoch. 1998. Activation of Rac
and Cdc42 by integrins mediates cell spreading. Mol. Biol. Cell. 9:1863–
1871.
Radhakrishna, H., O. Al-Awar, Z. Khachikian, and J.G. Donaldson. 1999. ARF6
requirement for Rac ruffling suggests a role for membrane trafficking in cor-
tical actin rearrangements. J. Cell Sci. 112:855–866.
Randazzo, P.A., J. Andrade, K. Miura, M.T. Brown, Y.Q. Long, S. Stauffer, P.
Roller, and J.A. Cooper. 2000. The Arf GTPase-activating protein ASAP1
regulates the actin cytoskeleton. Proc. Natl. Acad. Sci. USA. 97:4011–4016.
Ren, X.D., W.B. Kiosses, and M.A. Schwartz. 1999. Regulation of the small GTP-
binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18:
578–585.
Ridley, A.J., and A. Hall. 1992. The small GTP-binding protein rho regulates the
assembly of focal adhesions and actin stress fibers in response to growth fac-
tors. Cell. 70:389–399.
Ridley, A.J., H.F. Paterson, C.L. Johnston, D. Diekmann, and A. Hall. 1992. The
small GTP-binding protein rac regulates growth factor-induced membrane
ruffling. Cell. 70:401–410.
Riedy, M.C., M.C. Brown, C.J. Molloy, and C.E. Turner. 1999a. Activin A and
TGF-  stimulate phosphorylation of focal adhesion proteins and cytoskele-
tal reorganization in rat aortic smooth muscle cells. Exp. Cell Res. 251:194–
202.
Riedy, M.C., M.C. Brown, and C.E. Turner. 1999b. Analysis of paxillin as a multi-
domain scaffolding protein. In Methods in Signal Transduction-Signaling
Through Cell Adhesion Molecules. Vol. 1. J.-L. Guan, editor. CRC Press
LLC, Boca Raton, FL. 63–80.
Rottner, K., A. Hall, and J.V. Small. 1999. Interplay between Rac and Rho in the
control of substrate contact dynamics. Curr. Biol. 9:640–648.
Ruest, P.J., S. Roy, E. Shi, R.L. Mernaugh, and S.K. Hanks. 2000. Phosphospe-
cific antibodies reveal focal adhesion kinase activation loop phosphorylation
in nascent and mature focal adhesions and requirement for the autophos-
phorylation site. Cell Growth Differ. 11:41–48.
Salgia, R., J.L. Li, D.S. Ewaniuk, Y.B. Wang, M. Sattler, W.C. Chen, W. Rich-
ards, E. Pisick, E. Shapiro, B.J. Rollins, et al. 1999. Expression of the focal
adhesion protein paxillin in lung cancer and its relation to cell motility. On-
cogene. 18:67–77.
Sander, E.E., S. van Delft, J.P. ten Klooster, T. Reid, R.A. van der Kammen, F.
Michiels, and J.G. Collard. 1998. Matrix-dependent Tiam1/Rac signaling in
epithelial cells promotes either cell–cell adhesion or cell migration and is reg-
ulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143:1385–1398.
Sander, E.E., J.P. ten Klooster, S. van Delft, R.A. van der Kammen, and J.G. Col-
lard. 1999. Rac downregulates Rho activity: reciprocal balance between both
GTPases determines cellular morphology and migratory behavior. J. Cell
Biol. 147:1009–1022.
Schaller, M.D., J.D. Hildebrand, J.D. Shannon, J.W. Fox, R.R. Vines, and
J.T.  Parsons. 1994. Autophosphorylation of the focal adhesion kinase,
pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14:
1680–1688.
Schwartz, M.A., M.D. Schaller, and M.H. Ginsberg. 1995. Integrins: emerging
paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11:549–599.
Sells, M.A., U.G. Knaus, S. Bagrodia, D.M. Ambrose, G.M. Bokoch, and J. Cher-
noff. 1997. Human p21-activated kinase (Pak1) regulates actin organization
in mammalian cells. Curr. Biol. 7:202–210.
Sells, M.A., J.T. Boyd, and J. Chernoff. 1999. p21-activated kinase 1 (Pak1) regu-
lates cell motility in mammalian fibroblasts. J. Cell Biol. 145:837–849.
Sieg, D.J., C.R. Hauck, and D.D. Schlaepfer. 1999. Required role of focal adhe-
sion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 112:
2677–2691.
Sieg, D.J., C.R. Hauck, D. Ilic, C.K. Klingbeil, E. Schaefer, C.H. Damsky, and176 The Journal of Cell Biology | Volume 154, 2001
D.D. Schlaepfer. 2000. FAK integrates growth-factor and integrin signals to
promote cell migration. Nat. Cell Biol. 2:249–256.
Small, J.V., K. Anderson, and K. Rottner. 1996. Actin and the coordination of
protrusion, attachment and retraction in cell crawling. Biosci. Rep. 16:351–
368.
Tachibana, K., T. Sato, N. D’Avirro, and C. Morimoto. 1995. Direct association
of pp125FAK with paxillin, the focal adhesion-targeting mechanism of
pp125FAK. J. Exp. Med. 182:1089–1099.
Turner, C.E. 2000. Paxillin and focal adhesion signalling. Nature Cell Biology.
2:E231–E236.
Turner, C.E., and J.T. Miller. 1994. Primary sequence of paxillin contains putative
SH2 and SH3 domain binding motifs and multiple LIM domains: identifi-
cation of a vinculin and pp125Fak-binding region. J. Cell Sci. 107:1583–
1591.
Turner, C.E., M.C. Brown, J.A. Perrotta, M.C. Riedy, S.N. Nikolopoulos, A.R.
McDonald, S. Bagrodia, S. Thomas, and P.S. Leventhal. 1999. Paxillin LD4
motif binds PAK and PIX through a novel 95-kD ankyrin repeat, ARF-GAP
protein: a role in cytoskeletal remodeling. J. Cell Biol. 145:851–863.
Van Aelst, L., T. Joneson, and D. Bar-Sagi. 1996. Identification of a novel Rac1-
interacting protein involved in membrane ruffling. EMBO J. 15:3778–
3786.
Wood, C.K., C.E. Turner, P. Jackson, and D.R. Critchley. 1994. Characterisation
of the paxillin-binding site and the C-terminal focal adhesion targeting se-
quence in vinculin. J. Cell Sci. 107:709–717.
Yano, H., H. Uchida, T. Iwasaki, M. Mukai, H. Akedo, K. Nakamura, S. Hashi-
moto, and H. Sabe. 2000. Paxillin   and Crk-associated substrate exert op-
posing effects on cell migration and contact inhibition of growth through ty-
rosine phosphorylation. Proc. Natl. Acad. Sci. USA. 97:9076–9081.
Zhang, Q., J. Calafat, H. Janssen, and S. Greenberg. 1999. ARF6 is required for
growth factor- and rac-mediated membrane ruffling in macrophages at a
stage distal to rac membrane targeting. Mol. Cell. Biol. 19:8158–8168.
Zhao, Z.S., E. Manser, X.Q. Chen, C. Chong, T. Leung, and L. Lim. 1998. A con-
served negative regulatory region in  PAK: inhibition of PAK kinases reveals
their morphological roles downstream of Cdc42 and Rac1. Mol. Cell. Biol.
18:2153–2163.
Zhao, Z.S., E. Manser, T.H. Loo, and L. Lim. 2000. Coupling of PAK-interacting
exchange factor PIX to GIT1 promotes focal complex disassembly. Mol.
Cell. Biol. 20:6354–6363.